Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Moskalev

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Urologic Oncology|November 30, 2020
A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinomaClaudia Kesch, Veronika Schmitt, Samir Bidnur, et al.
Human Gene Therapy|June 20, 2018
The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder CancerEva Lichtenegger, Florestan Koll, Helena Haas, et al.
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
The Prostate|August 9, 2017
Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot studyWerner J Struss, Zheng Tan, Payam Zachkani, et al.
Plos One|April 5, 2013
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approachWolfgang Jäger, Igor Moskalev, Claudia Janssen, et al.
ACS Nanoscience Au|February 23, 2023
Robust Nanoparticle-Derived Lubricious Antibiofilm Coating for Difficult-to-Coat Medical Devices with Intricate GeometryHossein Yazdani-Ahmadabadi, Kai Yu, Sara Khoddami, et al.
Urologic Oncology|June 4, 2021
Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinomaTilman Todenhöfer, Ewan A Gibb, Roland Seiler, et al.
Oncotarget|October 1, 2024
Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|April 13, 2018
Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinomaSebastian Frees, Ines Breuksch, Tobias Haber, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Urologic Oncology|November 30, 2020
A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinomaClaudia Kesch, Veronika Schmitt, Samir Bidnur, et al.
Human Gene Therapy|June 20, 2018
The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder CancerEva Lichtenegger, Florestan Koll, Helena Haas, et al.
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
The Prostate|August 9, 2017
Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot studyWerner J Struss, Zheng Tan, Payam Zachkani, et al.
Plos One|April 5, 2013
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approachWolfgang Jäger, Igor Moskalev, Claudia Janssen, et al.
ACS Nanoscience Au|February 23, 2023
Robust Nanoparticle-Derived Lubricious Antibiofilm Coating for Difficult-to-Coat Medical Devices with Intricate GeometryHossein Yazdani-Ahmadabadi, Kai Yu, Sara Khoddami, et al.
Urologic Oncology|June 4, 2021
Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinomaTilman Todenhöfer, Ewan A Gibb, Roland Seiler, et al.
Oncotarget|October 1, 2024
Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.
Oncotarget|April 13, 2018
Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinomaSebastian Frees, Ines Breuksch, Tobias Haber, et al.
Pageof 4